miR-21 targets 15-PGDH and promotes cholangiocarcinoma growth.
about
Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancerMicroRNAs in the Cholangiopathies: Pathogenesis, Diagnosis, and TreatmentMultiple drug resistance-associated protein 4 (MRP4), prostaglandin transporter (PGT), and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) as determinants of PGE2 levels in cancerMicroRNAs and benign biliary tract diseasesDeregulated MicroRNAs in Biliary Tract Cancer: Functional Targets and Potential BiomarkersMicroRNAs in Cholangiopathies.Inflammation and MiR-21 pathways functionally interact to downregulate PDCD4 in colorectal cancerA microRNA profile associated with Opisthorchis viverrini-induced cholangiocarcinoma in tissue and plasma.MicroRNA-21 regulates prostaglandin E2 signaling pathway by targeting 15-hydroxyprostaglandin dehydrogenase in tongue squamous cell carcinomamiR-620 promotes tumor radioresistance by targeting 15-hydroxyprostaglandin dehydrogenase (HPGD).MicroRNA MIR21 and T Cells in Colorectal Cancer.Gene and microRNA modulation upon trabectedin treatment in a human intrahepatic cholangiocarcinoma paired patient derived xenograft and cell line.Knockout of microRNA-21 reduces biliary hyperplasia and liver fibrosis in cholestatic bile duct ligated mice.Exosomes in liver pathology.The S100P/RAGE signaling pathway regulates expression of microRNA-21 in colon cancer cells.The role of microRNAs in gallbladder cancer.The Emerging Role of miRNAs and Their Clinical Implication in Biliary Tract Cancer.MicroRNA MIR21 (miR-21) and PTGS2 Expression in Colorectal Cancer and Patient Survival.NcRNAs and Cholangiocarcinoma.MiR-433 and miR-22 dysregulations induce HDAC6 overexpression and ciliary loss in cholangiocarcinoma.miRNA profiling for diagnosis, prognosis and stratification of cancer treatment in cholangiocarcinoma.Elevation of miR-21, through targeting MKK3, may be involved in ischemia pretreatment protection from ischemia-reperfusion induced kidney injury.Circulating microRNA-21 (MIR-21) and phosphatase and tensin homolog (PTEN) are promising novel biomarkers for detection of oral squamous cell carcinoma.
P2860
Q26774690-4B9B8379-4936-4991-8B8E-F3911555A67DQ26783579-DF1A7B30-45D8-4275-9184-C201937D4166Q26828414-F238A930-3954-42EF-BE45-628B1C699395Q26865762-893CDDC3-8A3D-4B16-9A95-791C71F37689Q28073195-35F2B958-8EFC-4472-B6B2-32720AC23E30Q33991899-DED33A24-915A-4AAA-9277-5CDF15CE5D1FQ34332222-C446E8EC-CA51-4811-88FA-F72298F949E5Q35562369-F457DD8D-5762-4349-A4B8-F53499C3CDACQ36113576-248F86FA-D562-4A3F-A562-655BCE8A709EQ36355984-820CE512-A600-4193-B685-1278F0BC96EEQ36436728-10D9C4AC-713D-45FC-80BE-FF1154A05D11Q38728270-07018BA2-FBF5-4C11-B079-52F1D2B00BACQ38738028-745B20E3-83C6-4E38-897B-44932C2BA2F1Q38779087-E9B44BE6-9869-495A-9D21-0E2A67CB564AQ38851082-4C7C68DE-16F8-4240-AA26-46DA17597170Q38872859-6B374252-B31E-4893-9860-35E4C86D908CQ39099794-19383FCC-70BB-4067-9308-AADDF5920E89Q40864425-7E81897E-FEA8-4F62-BCAD-B867C85E84DDQ47153848-2BFA0F8E-56A7-4765-AC23-D791B6847A25Q50182542-B4227F7D-C549-42F0-8314-1D5C78087FEDQ53099936-D1AA5952-8D2D-4A8E-8DB0-1BC76591A709Q53437732-7C4F3CC3-F1CF-4F8B-90DE-493BFC64F36FQ54193247-0BA49D2F-41D2-46F8-B52A-16EEF8EA3796
P2860
miR-21 targets 15-PGDH and promotes cholangiocarcinoma growth.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
miR-21 targets 15-PGDH and promotes cholangiocarcinoma growth.
@ast
miR-21 targets 15-PGDH and promotes cholangiocarcinoma growth.
@en
type
label
miR-21 targets 15-PGDH and promotes cholangiocarcinoma growth.
@ast
miR-21 targets 15-PGDH and promotes cholangiocarcinoma growth.
@en
prefLabel
miR-21 targets 15-PGDH and promotes cholangiocarcinoma growth.
@ast
miR-21 targets 15-PGDH and promotes cholangiocarcinoma growth.
@en
P2093
P2860
P1476
miR-21 targets 15-PGDH and promotes cholangiocarcinoma growth.
@en
P2093
P2860
P304
P356
10.1158/1541-7786.MCR-13-0419
P577
2014-04-03T00:00:00Z